Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Sandra Meta Swain, MD for Medicare patients.
| doctor visit | 39 |
|---|
(No ratings)
Dr. Sandra Meta Swain, MD is a medical oncologist in Washington, DC specializing in medical oncology, adult oncology and adult hematology. She graduated from University of Florida College of Medicine in 1980 and has 46 years of experience. Dr. Sandra Meta Swain, MD is affiliated with MedStar Georgetown University Hospital, MedStar Washington Hospital Center and MedStar Health.
Anemia
Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.
An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.
Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.
Blood Transfusion
Blood transfusions typically treat those who experience a substantial loss of blood from an injury or surgical procedure, or those who suffer from conditions that alter the blood supply or blood components. For example, a blood transfusion may contribute additional red blood cells to someone with anemia, a condition where the body does not produce enough red blood cells. Other conditions may include:
When a patient has sufficient blood volume and lacks one or more components, a complete blood count (CBC) test can help determine if a patient requires a transfusion by measuring four blood components: red blood cells, white blood cells, platelets, and hemoglobin. If any of the patient's component counts is significantly below a standard range, the patient will likely need a blood transfusion. The complete blood count test uses a needle to extract a small amount of blood for testing.
Blood transfusion recipients should be tested for their blood type, which is one of four different types: type A, B, AB, or O. Patients with A, B, and O blood can only receive a blood donation matching their blood type or of O blood, which is known as the universal donor. Those with AB blood are considered "universal recipients"; they may receive A, B, AB, or O blood. Further complicating blood types is the presence or absence of the RhD antigen, adding a positive or negative modifier that should also be considered. Incompatible blood donations may cause transfusion sickness, such as a hemolytic reaction, where the body fights the donated red blood cells.
In certain emergency or trauma situations, medical teams often do not perform a complete blood count (CBC) test or blood type test. In those cases, patients are often given O negative blood, which is universally accepted. Some patients have their blood type on a medical card or bracelet, allowing emergency medical teams to issue compatible blood without testing.
Transfusions are performed by inserting a needle attached to an intravenous line (IV) into a vein in the body. This IV line is attached to a bag of blood that steadily dispenses blood into the patient's bloodstream. The type, volume, and components of donated blood depend on the patient's condition and needs. After the transfusion is complete, patients are generally permitted to resume normal activity, unless prohibited by a condition or injury. Some patients may experience bruising or soreness around the area that the needle was inserted.
At times, a second complete blood count test is performed to determine if the transfusion has brought patients' component counts to normal levels. Some patients may require multiple blood transfusions to reach a healthy blood volume and blood component count.
Once patients' blood volumes and components reach sufficient levels, they will generally begin to feel better. Patients of all ages, from newborn infants to elderly adults, can receive a blood transfusion.
Volume of procedures performed by Dr. Sandra Meta Swain, MD for Medicare patients.
| doctor visit | 39 |
|---|
Information about Medicare patients treated by Dr. Sandra Meta Swain, MD.
| Male | 0 |
|---|---|
| Female | 15 |
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 75 |
Information about Medicare patients treated by Dr. Sandra Meta Swain, MD.
| Male | 0 |
|---|---|
| Female | 19 |
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 75 |
Information about Medicare patients treated by Dr. Sandra Meta Swain, MD.
| Male | 0 |
|---|---|
| Female | 38 |
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Sandra Meta Swain, MD for Medicare patients.
| doctor visit | 39 |
|---|
Information about Medicare patients treated by Dr. Sandra Meta Swain, MD.
| Male | 0 |
|---|---|
| Female | 18 |
The highest averages of the most common conditions of Medicare patients that Dr. Sandra Meta Swain, MD treated were cancer.
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoporosis | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Atrial Fibrillation | 0 |
| Cancer | 56 |
| Dementia | 0 |
Dr. Sandra Meta Swain, MD graduated from University of Florida College of Medicine in 1980. She completed residency at Vanderbilt University Medical Center. She is certified by the American Board of Internal Medicine, Internal Medicine and has a state license in Maryland.
Medical School: University of Florida College of Medicine (1980)
Residency: Vanderbilt University Medical Center (1983)
Board Certification: American Board of Internal Medicine, Internal Medicine
Licensed In: Maryland
Dr. Sandra Meta Swain, MD is associated with these hospitals and organizations:
Dr. Sandra Meta Swain, MD does not have any reviews yet, be the first to leave a review of Dr. Sandra Meta Swain, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Sandra Meta Swain, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Pfizer Inc. |
$811,633
IBRANCE $4,892 |
$806,742 |
||||
|---|---|---|---|---|---|---|
| F. Hoffmann-La Roche AG |
$69,529
Perjeta $31,322 |
TECENTRIQ $18,197 |
Kadcyla $10,633 |
Herceptin $7,952 |
Xeloda $500 |
Other $926 |
| AstraZeneca UK Limited |
$33,889
FASLODEX $14,163 |
Enhertu $2,398 |
LYNPARZA $566 |
$16,762 |
||
| Daiichi Sankyo Inc. |
$23,840
Enhertu $7,130 |
$16,710 |
||||
| Eli Lilly and Company |
$22,180
VERZENIO $3,649 |
$18,531 |
||||
| Other |
$79,688
MYTESI $17,333 |
FASLODEX $15,788 |
Non-Covered Product $4,287 |
Perjeta $4,010 |
NonCovered Product $3,935 |
Other $34,335 |
| Acquisitions | $806,742 |
|---|---|
| Consulting Fee | $175,362 |
| Travel and Lodging | $44,479 |
| Food and Beverage | $6,872 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,252 |
| Other | $3,054 |
Dr. Sandra Meta Swain, MD has received 68 research payments totaling $477,277.
Dr. Sandra Swain is a specialist in adult hematology, adult oncology, and medical oncology. Her clinical interests include bladder cancer, vitamin deficiencies, and colon cancer. Dr. Swain obtained her medical school training at the University of Florida College of Medicine and performed her residency at Vanderbilt University Medical Center and National Institutes of Health (NIH). Her professional affiliations include MedStar Georgetown University Hospital and MedStar Washington Hospital Center.